Nikola Bangemann

Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results

Oleg Gluz, Ulrike Nitz, Cornelia Liedtke et al. · JNCI Journal of the National Cancer Institute · 2017 · 122 citations · Full text

Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes

Gerhard Schäller, Ilka Fuchs, Thomas Gonsch et al. · Journal of Clinical Oncology · 2007 · 100 citations · Full text

Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy

Petra Huehnchen, Christian Schinke, Nikola Bangemann et al. · JCI Insight · 2022 · 80 citations · Full text

Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer—Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling

Scarlet Brockmöller, Elmar Bucher, Berit Müller et al. · Journal of Proteome Research · 2011 · 75 citations

Lipid Analysis, Hormone Receptor Status, Breast Oncology +20

The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions

Berit Müller, E. Keil, Annika Lehmann et al. · PLoS ONE · 2013 · 74 citations · Full text

Breast Oncology, Clinical Endpoint, Immunology +20